20-F: Meiwu Technology Shifts Focus to Skincare, Reports Financial Results for Fiscal Year 2024

Meiwu Technology Company Limited transitions to functional skincare business while reporting its financial results for the year ended December 31, 2024, including a significant increase in net income due to the disposal of subsidiaries.

Summary

• Meiwu Technology Company Limited reports its financial results for the fiscal year ended December 31, 2024.
• The company has strategically shifted its focus to the functional skincare business, which accounted for 38% of total revenue in 2024.
• The VIE structure was terminated in December 2024 due to continued losses and the business transition.
• Net revenue decreased to $158,485 in 2024 from $10,977,429 in 2023, primarily due to the cessation of the SMS business.
• Net income significantly increased to $5,114,684 in 2024, compared to a net loss of $16,312,705 in 2023, mainly due to gains from the disposal of subsidiaries.
• The company's gross profit was $67,131 in 2024, a decrease from $2,583,065 in 2023.
• The company reported a loss from operations of $2,047,017 in 2024, compared to a loss of $1,516,786 in 2023.
• Basic and diluted income per share was $0.16 in 2024, compared to a loss per share of $6.54 in 2023.
• The company's cash and cash equivalents increased to $43,396,977 as of December 31, 2024, from $16,062,047 as of December 31, 2023.
• The company effectuated a reverse split of its Ordinary Shares on an one-for-twenty basis on April 1, 2025.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While the company's strategic shift to skincare and improved cash position are positive, the significant revenue decline and ongoing risks associated with operating in China temper the overall outlook.

Positives

• The company's strategic shift to the functional skincare business presents a new avenue for growth.
• The termination of the VIE structure simplifies the company's corporate structure.
• The company's cash position significantly improved, reaching $43,396,977 as of December 31, 2024.
• The company reported a net income of $5,114,684 in 2024, a significant turnaround from the net loss of $16,312,705 in 2023.

Negatives

• The significant decrease in net revenue to $158,485 in 2024 from $10,977,429 in 2023 indicates a substantial contraction in business activity.
• The company reported a loss from operations of $2,047,017 in 2024, compared to a loss of $1,516,786 in 2023.

Risks

• The company faces uncertainties regarding the interpretation and enforcement of PRC laws and regulations.
• The company's securities may be prohibited from trading in the United States under the HFCAA if the PCAOB is unable to inspect or investigate completely the company's auditor.
• Any actions by the Chinese government could limit or completely hinder the company's ability to offer securities to investors.
• The company's success is dependent on the popularity of its products and its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner.
• The company relies on third-party service providers for logistics services, and failure of these providers could adversely affect the business.
• The company may be subject to infringement claims of intellectual property rights or other rights of third parties, which may be expensive to defend and may disrupt the business and operations.

Future Outlook

The company aims to build a comprehensive online ecosystem with a stable supply chain for its functional skincare products, expected to launch around the last quarter of 2025.

Industry Context

The functional skincare industry is experiencing growth, particularly in China, driven by consumer demand for ingredient transparency and product efficacy.

Comparison to Industry Standards

• The report mentions competitors such as Winona, Pechoin, and Chando, each with franchisees nationwide, which will continue to present significant challenges.
• These competitors are expected to maintain their advantages due to their longer operating histories, higher market shares, and established brand recognition, which may affect our ability to gain visibility and credibility among consumers.
• Furthermore, larger and more established companies will likely benefit from economies of scale, enabling them to produce goods at lower costs per unit.

Related Party Transactions

• The company borrowed loans as working capital from its chairman of the board, Changbin Xia, with a balance of $1,287,629 as of December 31, 2024.

Stakeholder Impact

• Shareholders may experience volatility in the share price due to the company's strategic shift and the risks associated with operating in China.
• Customers may benefit from the company's focus on functional skincare products, which are designed to address specific dermatological concerns.

Next Steps

• The company plans to expand its partnership with research institutions to develop new functional skincare formulas and products.
• The company also seeks to develop a network of distributors in the second and third tier cities in China, then organically develop new channels of distribution and new sales relationships across the country.

Key Dates

Keywords

functional skincare, financial results, VIE termination, net income, revenue, China, Meiwu Technology